title: Integument structure and function in juvenile Xenopus laevis with disrupted thyroid balance.
abstract: The skin is the largest organ in the body and is a barrier between the internal and external environment. The present study evaluates how PTU, a goitrogen, that is used to treat hyperthyroidism affects the structure and electrical properties of the frog (Xenopus laevis) skin. The results are considered in the context of the two-membrane model established in the seminal work of Ussing and collegues in the 1940s and 1950s. In vitro experiments with skin from Xenopus adults revealed that PTU can act directly on skin and causes a significant increase (p<0.05, One-way ANOVA) in short circuit current (Isc) via an amiloride-insensitive mechanism. Juvenile Xenopus exposed to waterborne PTU (5 mg/L) had a significantly bigger and more active thyroid gland (p<0.01, Student's t-test) than control Xenopus. The bioelectric properties of skin taken from Xenopus juveniles treated with PTU in vivo had a lower Isc, (3.05±0.4, n=13) and Rt (288.2±39.5) than skin from control Xenopus (Isc, 4.19±1.14, n=14; Rt, 343.3±43.3). A histological assessment of skin from PTU treated Xenopus juveniles revealed the epidermis was significantly thicker (p<0.01, Student's t-test) and had a greater number of modified exocrine glands (p<0.01, Student's t-test) in the dermis compared to control skin. Modifications in skin structure are presumably the basis for its changed bioelectric properties and the study highlights a site of action for environmental chemicals which has been largely neglected.
authors.affiliation: Centro de Ciências do Mar, CIMAR-Laboratório Associado, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
authors.forename: Edison S M
authors.initials: ES
authors.lastname: Carvalho
authors.forename: Juan
authors.initials: J
authors.lastname: Fuentes
authors.forename: Deborah M
authors.initials: DM
authors.lastname: Power
mesh_terms: D000367:Age Factors; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D013956:Antithyroid Agents / Q000494:pharmacology*; D055724:Electrophysiological Phenomena / Q000187:drug effects; D052244:Endocrine Disruptors / Q000494:pharmacology; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology; D034582:Integumentary System / Q000033:anatomy & histology* / Q000502:physiology*; D011441:Propylthiouracil / Q000494:pharmacology*; D012867:Skin / Q000187:drug effects; D012879:Skin Physiological Phenomena / Q000187:drug effects; D026941:Sodium Channel Blockers / Q000494:pharmacology; D013961:Thyroid Gland / Q000187:drug effects* / Q000502:physiology; D014867:Water / Q000494:pharmacology; D014982:Xenopus laevis / Q000378:metabolism / Q000502:physiology*
chemical_list: D013956:Antithyroid Agents; D052244:Endocrine Disruptors; D026941:Sodium Channel Blockers; D014867:Water; D011441:Propylthiouracil; D000584:Amiloride